Freshworks Inc vs Humana Inc — how do they compare? Freshworks Inc trades at $13.92 (market cap $3.56B), while Humana Inc trades at $431.03 (market cap $46.49B). The key difference: Humana Inc is far larger — about 13.1× Freshworks Inc's market cap, and Humana Inc pays a 0.91% dividend while Freshworks Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Freshworks Inc for 39 Days and Humana Inc for 51 Days on average.
| FRSH | HUM | |
|---|---|---|
Market Cap | $3.56B | $46.49B |
Volume | 9,066,454 | 2,567,704 |
Sector | Technology | Health |
52-Week High | $13.92 | $431.03 |
52-Week Low | $6.88 | $163.67 |
Typical Hold Time | 39 Days | 51 Days |
Enterprise Value | $2.93B | $53.84B |
Dividend Yield | — | 0.91% |
Signals from Pluang's Aura AI — not financial advice
Freshworks (FRSH) trades at $13.64, up 0.29% with strong technical momentum showing bullish moving average signals. The company achieved its first GAAP profitability in Q2 2026 with revenue growth of 16% year-over-year, beating earnings expectations. Recent developments include FedRAMP certification progress and leadership in Gartner's ITSM Magic Quadrant, positioning the company for enterprise growth.
FRSH presents a compelling investment case with attractive valuation metrics (P/E 21.63, P/S 4.28) and strong profitability margins (84.96% gross margin, 20.49% net margin). However, elevated EV/EBITDA (43.89) and competitive SaaS market pressures require monitoring. Analyst consensus is evenly split between Buy and Hold with $14.60 price target suggesting modest upside potential from current levels.
Humana (HUM) trades at $387.12, down 2.37% today, with a bullish technical outlook supported by moving averages and strong institutional interest. The company shows steady revenue growth reaching $129.7B in 2025, though net margins have compressed to 0.88%. Recent analyst upgrades and a $460.74 consensus price target suggest upside potential, while Medicare Advantage plan changes and fiduciary scrutiny present near-term headwinds.
The stock offers value with a low P/S ratio of 0.32x and consistent earnings beats, but faces margin pressure and regulatory risks. Institutional accumulation and positive technicals support a constructive outlook, though investors should monitor enrollment trends and cost management execution for sustained growth.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Freshworks Inc provides software as a service platform that enables small and medium-sized businesses to support customers through e-mail, phone, website, and social networks. It offers solutions that serve the needs of users in the CX and ITSM categories, and have also expanded its offering with Sales and Marketing automation products. These product offerings enable organizations to acquire, engage, and better serve their customers and employees.
Read more on FRSH →Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →